Aquatic Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Aquatic Capital Management’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$596K	Buy	+24,061	New	+$573K	0.02%	703
2025 Q2	–	Sell	-70,066	Closed	-$1.7M	–	1284
2025 Q1	$1.7M	Buy	70,066 +40,805	+139%	+$919K	0.04%	455
2024 Q4	$611K	Sell	29,261 -18,008	-38%	-$387K	0.02%	673
2024 Q3	$940K	Buy	47,269 +32,569	+222%	+$604K	0.02%	513
2024 Q2	$228K	Buy	14,700 +5,200	+55%	+$81K	0.01%	722
2024 Q1	$151K	Buy	+9,500	New	+$143K	﹤0.01%	830
2023 Q4	–	Sell	-31,700	Closed	-$371K	–	1375
2023 Q3	$371K	Buy	+31,700	New	+$424K	0.02%	544
2023 Q2	–	Sell	-103,400	Closed	-$1.71M	–	1408
2023 Q1	$1.71M	Buy	+103,400	New	+$1.71M	0.11%	211
2022 Q4	–	Sell	-300	Closed	-$4K	–	1443
2022 Q3	$4K	Sell	300 -7,500	-96%	-$88.9K	﹤0.01%	1096
2022 Q2	$55K	Buy	+7,800	New	+$57.2K	0.02%	623

Other funds holding CPRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Aquatic Capital Management's CPRX Position: Q1 2026 in Review

Aquatic Capital Management opened a new position in Catalyst Pharmaceutical (CPRX) in Q1 2026: 24,061 shares worth $596K. The stake represents 0.02% of the portfolio and ranks #703 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in CPRX as recently as Q1 2025.

Aquatic Capital Management first reported a position in CPRX in Q2 2022 and has held it in 10 quarters since. The position peaked at $1.71M in Q1 2023. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

Aquatic Capital Management held 24,061 shares of Catalyst Pharmaceutical worth $596K as of Q1 2026.
Catalyst Pharmaceutical was a new Aquatic Capital Management position in Q1 2026.
Catalyst Pharmaceutical made up 0.02% of Aquatic Capital Management's portfolio in Q1 2026, its #703 holding.
Aquatic Capital Management first reported a position in Catalyst Pharmaceutical in Q2 2022 and has held it in 10 quarters since.
Aquatic Capital Management's Catalyst Pharmaceutical position peaked at $1.71M in Q1 2023.
380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.